SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+7.05%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$427M
AUM Growth
+$427M
(+54%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
32.43%
Top 10 Holdings %
Top 10 Hldgs %
57.06%
Holding
143
New
47
Increased
27
Reduced
21
Closed
35
Top Buys
| 1 |
Novartis
NVS
|
$42.9M |
| 2 |
Sanofi
SNY
|
$33.4M |
| 3 |
Johnson & Johnson
JNJ
|
$21.2M |
| 4 |
Eli Lilly
LLY
|
$17.7M |
| 5 |
Merck
MRK
|
$14.2M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$9.18M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$7.75M |
| 3 |
Invesco QQQ Trust
QQQ
|
$7.1M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$4.67M |
| 5 |
Apple
AAPL
|
$3.1M |
Sector Composition
| 1 | Healthcare | 75.14% |
| 2 | Consumer Discretionary | 3.07% |
| 3 | Technology | 2.73% |
| 4 | Industrials | 1.88% |
| 5 | Consumer Staples | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Teva Pharmaceuticals
TEVA
$21.5B
| $3.26M | 0.74% |
61,600
-88,400
| -59% | -$4.67M |
|
27
Alphabet (Google) Class C
GOOG
$2.78T
| $3.19M | 0.73% |
+2,864
| New | +$3.19M |
|
|
PCP
28
DELISTED
PRECISION CASTPARTS CORP
PCP
| $3.17M | 0.72% |
12,520
+2,000
| +19% | +$506K |
|
29
Industrial Select Sector SPDR Fund
XLI
$23B
| $2.86M | 0.65% |
54,623
-40,000
| -42% | -$2.09M |
|
|
CLVS
30
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.77M | 0.63% |
40,000
-5,000
| -11% | -$346K |
|
31
CVS Health
CVS
$93B
| $2.68M | 0.61% |
+35,795
| New | +$2.68M |
|
32
Booking.com
BKNG
$180B
| $2.67M | 0.61% |
2,242
+267
| +14% | +$318K |
|
|
TBRA
33
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $2.5M | 0.57% |
+200,000
| New | +$2.5M |
|
|
RDHL
34
Redhill Biopharma
RDHL
$2.92M
| $2.43M | 0.55% |
+1,714,880
| New | +$2.43M |
|
35
Neurogene
NGNE
$276M
| $2.42M | 0.55% |
+190,000
| New | +$2.42M |
|
|
AERI
36
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.38M | 0.54% |
112,500
+2,500
| +2% | +$53K |
|
|
NPSP
37
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $2.34M | 0.53% |
78,000
-50,000
| -39% | -$1.5M |
|
38
Las Vegas Sands
LVS
$38.2B
| $2.25M | 0.51% |
27,847
+3,170
| +13% | +$256K |
|
|
CASC
39
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $2.21M | 0.5% |
738,336
-10,000
| -1% | -$29.9K |
|
|
IRD
40
Opus Genetics, Inc. Common Stock
IRD
$76.1M
| $2.17M | 0.49% |
2,006,200
+506,200
| +34% | +$547K |
|
41
Prothena Corp
PRTA
$442M
| $2.11M | 0.48% |
55,000
+5,000
| +10% | +$192K |
|
42
Nova
NVMI
$7.14B
| $2.03M | 0.46% |
+181,184
| New | +$2.03M |
|
43
Silicom
SILC
$92.9M
| $1.99M | 0.45% |
32,088
-5,733
| -15% | -$356K |
|
|
TRVN
44
DELISTED
Trevena, Inc.
TRVN
| $1.97M | 0.45% |
+250,000
| New | +$1.97M |
|
45
Galmed Pharmaceuticals
GLMD
$7.07M
| $1.95M | 0.45% |
+170,000
| New | +$1.95M |
|
46
Charles Schwab
SCHW
$175B
| $1.89M | 0.43% |
69,200
-28,727
| -29% | -$785K |
|
|
ITCI
47
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.82M | 0.42% |
+100,000
| New | +$1.82M |
|
48
Check Point Software Technologies
CHKP
$20.4B
| $1.79M | 0.41% |
26,513
-28,840
| -52% | -$1.95M |
|
|
FPRX
49
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.77M | 0.4% |
+90,000
| New | +$1.77M |
|
|
SMMF
50
DELISTED
Summit Financial Group, Inc.
SMMF
| $1.75M | 0.4% |
+10,921,656
| New | +$1.75M |
|